Recent Trends in Cardiovascular Mortality in the United States and Public Health Goals

Importance  Heart disease (HD) and cancer are the 2 leading causes of death in the United States. During the first decade of the 21st century, HD mortality declined at a much greater rate than cancer mortality and it appeared that cancer would overtake HD as the leading cause of death.

Objectives  To determine whether changes in national trends had occurred in recent years in mortality rates due to all cardiovascular disease (CVD), HD, stroke, and cancer and to evaluate the gap between mortality rates from HD and cancer.

Design, Setting, and Participants  The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research data system was used to determine national trends in age-adjusted mortality rates due to all CVD, HD, stroke, and cancer from January 1, 2000, to December 31, 2011, and January 1, 2011, to December 31, 2014, overall, by sex, and by race/ethnicity. The present study was conducted from December 30, 2105, to January 18, 2016.

Main Outcomes and Measures  Comparison of annual rates of change and trend in gap between HD and cancer mortality rates.

Results  The rate of the decline in all CVD, HD, and stroke mortality decelerated substantially after 2011, and the rate of decline for cancer mortality remained relatively stable. Reported as percentage (95% CI), the annual rates of decline for 2000-2011 were 3.79% (3.61% to 3.97%), 3.69% (3.51% to 3.87%), 4.53% (4.34% to 4.72%), and 1.49% (1.37% to 1.60%) for all CVD, HD, stroke, and cancer mortality, respectively; the rates for 2011-2014 were 0.65% (−0.18% to 1.47%), 0.76% (−0.06% to 1.58%), 0.37% (−0.53% to 1.27%), and 1.55% (1.07% to 2.04%), respectively. Deceleration of the decline in all CVD mortality rates occurred in males, females, and all race/ethnicity groups. For example, the annual rates of decline for total CVD mortality for 2000-2011 were 3.69% (3.48% to 3.89%) for males and 3.98% (3.81% to 4.14%) for females; for 2011-2014, the rates were 0.23% (−0.71% to 1.16%) and 1.17% (0.41% to 1.93%), respectively. The gap between HD and cancer mortality persisted.

Conclusions and Relevance  Deceleration in the decline of all CVD, HD, and stroke mortality rates has occurred since 2011. If this trend continues, strategic goals for lowering the burden of CVD set by the American Heart Association and the Million Hearts Initiative may not be reached.

JAMA Cardiol. Published online June 29, 2016. doi:10.1001/jamacardio.2016.1326

A cura di Calogero Calcullo

Rubriche

BANDO COMPONENTE COMITATO SCIENTFICO

CANDIDATURA A COMPONENTE DEL COMITATO SCIENTIFICO INTERNO. A breve, data termine presentazione domanda. Inviare la domanda compilata a: segreteria.direzione@ancecardio.it Scarica il bando Scarica il fax simile...

L’ INTELLIGENZA ARTIFICIALE IN CARDIOLOGIA

MAURIZIO BARONI Bologna, cardiologo libero professionista, segretario regionale ANCE Emilia-Romagna, vicepresidente regionale SIT Emilia-RomagnaScarica articolo L’intelligenza artificiale (IA) sta entrando sempre di più nell’ambito medico tanto da modificare e...

DETERMINAZIONE REGIONE LAZIO

Iscrizione dell’Ente A.N.C.E. - CARDIOLOGIA ITALIANA DEL TERRITORIO (rep. n. 142031, CF 94013530483) nella sezione ALTRI ENTI DEL TERZO SETTORE ai sensi dell?articolo 22 del D. Lgs. del 3 luglio 2017 n. 117 e dell?articolo 16 del Decreto Ministeriale n. 106 del...

Lo studio ASSURE DES

Giuseppe Strano Cardiologo Specialista Ambulatoriale c/o ASL Brindisi Segretario Provinciale ANCE, Brindisi Scarica articolo Le attuali linee guida raccomandano di rimandare la chirurgia elettiva per almeno 6 o 12 mesi dopo un intervento coronarico percutaneo, di...

FIBRILLAZIONE ATRIALE E SPORT

MAURIZIO BARONI Segretario Regionale ANCE Emilia RomagnaScarica articolo La fibrillazione atriale è una delle aritmie più frequenti e clinicamente significative; colpisce infatti un numero elevato di persone prevalentemente in età avanzata (fino al 10 % della...